Company profile

Calendar

6 Mar 19
21 Jul 19
31 Dec 19

News

Company financial data Financial data

Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 1.5B 1.42B 1.34B 1.28B
Net income 190.38M 40.39M 80.4M 130.15M
Diluted EPS 0.82 0.17 0.34 0.55
Net profit margin 12.68% 2.85% 6.01% 10.16%
Operating income 266.58M 153.42M 98.83M 179.5M
Net change in cash 501.37M 218.53M 149.17M -102.66M
Cash on hand 1.16B 657.71M 439.18M 290.01M
Cost of revenue 500.89M 494.98M 493.34M 454.33M

Financial data from Qiagen earnings reports

Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: AACR, Academy, alpelisib, anonymized, antimicrobial, anytime, ARESdb, ASH, Barcelona, BIOSCIENCE, Boehringer, Brexit, cardiovascular, carrier, chemotherapy, circumstance, clean, compensatory, consortia, constrained, contemporary, correct, customizable, cybersecurity, cystic, de, depict, disaggregate, disaggregation, disregarded, divergent, diversified, Diversifying, DNeasy, Earth, editing, Ellume, epidermal, expedient, FastSelect, feed, Fidelio, formula, Formulatrix, fraudulent, fungal, GBS, gonorrhoeae, Hamilton, healthy, hereof, Hodgkin, hormone, immature, immunotherapy, Ingelheim, Interbank, interface, invoice, invoiced, invoicing, IVDR, Leipzig, LIAISON, London, LungCancer, MDAX, MetaSUB, Migration, Minden, myeloma, Natera, NeuMoDx, Nevada, Nonemployee, novo, orderly, PACT, perpetual, Pfizer, posed, possession, Postbank, postmarket, PowerSoil, predetermined, ProstateCancerPanel, push, quicker, ramp, Reaping, reinforcing, reorganization, repetitive, SRL, straddle, stranded, synchronized, syndromic, tailored, TMB, tradable, UCP, ultrasensitive, UMI, unbilled, unclear, upfront, upward, vendor, VIE, whichever, won
Removed: Abbott, adjunctive, AdnaGen, attractive, branch, BreastCancer, broaden, broker, called, cancelled, Carlsbad, cell, certifying, client, collectability, compact, consigned, consignment, consumption, curated, deliverable, demanding, digit, discontinuation, displacing, downstream, earliest, easy, EMD, emergency, equivocal, era, escrow, ESEQuant, expertly, expression, feedback, FIFO, Fisher, foregoing, Franklin, glucose, greatly, Grundstuecksverwaltungsgesellschaft, guaranteed, headcount, headwind, Hong, house, includable, Ingenuity, Inhibitor, IPO, Kong, Korean, LDT, lengthy, liquidated, livestock, loaned, Malaysia, Marseille, mbH, Merck, Millipore, Modaplex, neglect, older, optical, Pap, partly, perjury, persuasive, petition, plate, portable, preacquisition, Promega, pure, pursuing, QIAgility, QIAxcel, ratably, reagent, recover, relapse, remote, risky, Roche, roll, sharply, side, standardize, subdivision, succeed, surpassing, surtax, synergistic, Taiwan, tapping, tariff, Thermo, tube, twenty, unconsolidated, undisclosed, unprecedented, unsubordinated, urge, variant, visualizing, VSOE, warehouse, water

Proxies

No filings